[1]
“ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA IN THE ERA OF NOVEL THERAPIES: CHANGING INDICATIONS AND DYNAMIC RISK ASSESSMENT”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026088, Oct. 2026, doi: 10.4084/MJHID.2026.088.